Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Contract Manufacturing Services

The New CDMO on the Block

| Stephanie Sutton

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.

Business & Regulation Business Practice

Introducing The Medicine Maker Company of the Year Awards

For 2022, we are very excited to launch The Medicine Maker Company of the Year Awards.

Business & Regulation Business Practice

The Power List is Back for 2022!

Nominations are now open for The Medicine Maker 2022 Power List!

Business & Regulation Business Practice

With Great Power…

| Maryam Mahdi

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Business & Regulation Profession

Scaling Advanced Therapies

| Angus Stewart

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

Business & Regulation Business Practice

Ad Men of the Round Table

| Angus Stewart

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.

Business & Regulation Business Practice

A Four Dimensional Perspective

Charlie Badham of 4D Pharma tells us his approach to social media in an age of outrage and tonal mixups.

Business & Regulation Business Practice

HyperReality Check

| Angus Stewart

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

Manufacture Contract Manufacturing Services

Responding to Changing Needs

| Sponsored by PCI

When it comes to delivering medicines to patients in need, choosing the right packaging partner can make all the difference.

Business & Regulation Standards & Regulation

Lobby and Legislature Play Pricing Plan Ping Pong

| Angus Stewart

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.

Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine